GlycoMimetics (NASDAQ:GLYC) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research note issued to investors on Saturday. The brokerage issued a sell rating on the biotechnology company’s stock. GlycoMimetics Stock Performance GlycoMimetics stock opened at $0.33 on Friday. The firm has a 50-day moving average of $0.27 and a 200-day moving average […]

Leave a Reply

Your email address will not be published.

Previous post Synopsys (SNPS) to Release Quarterly Earnings on Wednesday
Next post StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV)